Z-2140-2018 Class III Terminated
FDA device recall Z-2140-2018 was initiated by Alere San Diego Inc. DBA Immunalysis Corporation on Nov 28, 2017 and is designated Class III. Reason for recall: The High (125 ng/ml) Control does not meet specification - it has been confirmed to produce values below 100 ng/mL when run on validated clinical chemistry analyzers, which is below the 100 ng/mL… The recall status is terminated (terminated Jan 29, 2021). Affected quantity: 37 kits.
Recall details
- Product Type
- Devices
- Report Date
- Jun 20, 2018
- Initiation Date
- Nov 28, 2017
- Termination Date
- Jan 29, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 37 kits
Product description
lmmunalysis EDDP Urine Control Set 1 The EDDP Urine Controls (High 125 ng/ml and Low 75 ng/ml) are used as control materials in the ammonolysis EDDP Specific Urine Enzyme Immunoassay, which has a cutoff of 100 ng/ml. This test provides only a preliminary analytical test result and a more specific alternate chemical method, such as Gas Chromatography/Mass Spectrometry or Liquid Chromatography/Tandem Mass Spectrometry, must be used to obtain a confirmed analytical result.
Reason for recall
The High (125 ng/ml) Control does not meet specification - it has been confirmed to produce values below 100 ng/mL when run on validated clinical chemistry analyzers, which is below the 100 ng/mL cutoff of the EDDP Specific Urine Enzyme Immunoassay with which this control is utilized.
Distribution pattern
US Distribution to the states of : CA, CO, CT, FL, LA, MD, NC, NJ, OH, OK, TN, TX, WI, and WV
Code information
Part Number: 3006-5, Lot Number: EK16135
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-2140-2018
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026